jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Mar. 31, 2020

April. 24, 2023

jRCTc030190273

Exploratory clinical study to evaluate the safety of Platelet rich plasma transplantation for wound healing at the extracted socket. (Platelet rich plasma transplantation for wound healing of the extracted socket)

Platelet rich plasma transplantation for wound healing of the extracted socket (Platelet rich plasma transplantation for wound healing of the extracted socket)

Takahashi Kazuhisa

Aug. 26, 2021

2

Patient diagnosed with periodontitis of the wisdom tooth and tooth extraction is appropriate.

Two patients underwent PRP treatment and were evaluated for safety.

No serious adverese events or diseases related to regenerative medicine were observed during the observation period.

The safety of transplantation of platelet-rich plasma into the extraction socket was confirmed.

The safety of transplantation of platelet-rich plasma into the extraction socket after extraction of a wisdom tooth was evaluated,and a certain validity was confirmed.

Dec. 01, 2022

https://jrct.mhlw.go.jp/latest-detail/jRCTc030190273

Tobita Morikuni

Juntendo Hospital, Juntendo university school of medicine

3-1-3 Hongo Bunkyou-ku Tokyo

+81-3-3813-3111

mtobita@juntendo.ac.jp

Masubuchi Yosuke

Juntendo university

2-1-1, Hongo Bunkyou-ku Tokyo

+81-3-3813-3111

y-masubuchi@juntendo.ac.jp

2

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

A patient MUST:
1) Have wisdom teeth that it is believed appropriate to carry out tooth extraction.
2) Have good systemic condition.
3) Number of platelet is over 1x10E5 /microliter.
4) 20 years and older.
5) Other,the investigator believes makes him/her suitable for participation in this clinical study.

Patient MUST NOT
1) Have a history of Complicate malignant tumor.
2) Have an abnormal gingival proliferation or having a history of abnormal gingival proliferation.
3) Suspected of oral malignant tumor or precancerous lesion.
4) Under 20 years of old.
5) Have anti-coagulant or anti-platelet medications, or have a bleeding disorders.
6) Pregnancy, during breastfeeding, or possibility of pregnancy.
7) Other,the investigator believes makes him/her unsuitable for participation in the clinical study.

20age old over
No limit

Both

Pericoronitis of wisdom tooth

administration of cell processing products.

Safety

Efficacy

Mar. 15, 2019

Complete

Tokyo Medical and Dental University Specially Certified Committee for Regenerative Medicine
1-5-45, Yushima, Bunkyo-ku, Tokyo

+81-3-5803-4162

kenkyo.adm@cmn.tmd.ac.jp
Approval

Mar. 14, 2019

UMIN000036233
University hospital Medical Information Network (UMIN) Center

History of Changes

No Publication date
5 April. 24, 2023 (this page) Changes
4 April. 15, 2022 Detail Changes
3 July. 13, 2021 Detail Changes
2 July. 17, 2020 Detail Changes
1 Mar. 31, 2020 Detail